<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.8" -->
<?xml-stylesheet href="https://wiki.brewerideas.ca/lib/exe/css.php?s=feed" type="text/css"?>
<rdf:RDF
    xmlns="http://purl.org/rss/1.0/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
    xmlns:dc="http://purl.org/dc/elements/1.1/">
    <channel rdf:about="https://wiki.brewerideas.ca/feed.php">
        <title>Brewer Spectrometer Wiki the_breakthrough_of_glp1-r_peptide</title>
        <description></description>
        <link>https://wiki.brewerideas.ca/</link>
        <image rdf:resource="https://wiki.brewerideas.ca/lib/tpl/dokuwiki/images/favicon.ico" />
       <dc:date>2026-04-09T03:28:12+00:00</dc:date>
        <items>
            <rdf:Seq>
                <rdf:li rdf:resource="https://wiki.brewerideas.ca/doku.php?id=the_breakthrough_of_glp1-r_peptide:a_new_era_in_diabetes_and_obesity&amp;rev=1775555664&amp;do=diff"/>
            </rdf:Seq>
        </items>
    </channel>
    <image rdf:about="https://wiki.brewerideas.ca/lib/tpl/dokuwiki/images/favicon.ico">
        <title>Brewer Spectrometer Wiki</title>
        <link>https://wiki.brewerideas.ca/</link>
        <url>https://wiki.brewerideas.ca/lib/tpl/dokuwiki/images/favicon.ico</url>
    </image>
    <item rdf:about="https://wiki.brewerideas.ca/doku.php?id=the_breakthrough_of_glp1-r_peptide:a_new_era_in_diabetes_and_obesity&amp;rev=1775555664&amp;do=diff">
        <dc:format>text/html</dc:format>
        <dc:date>2026-04-07T09:54:24+00:00</dc:date>
        <dc:creator>Anonymous (anonymous@undisclosed.example.com)</dc:creator>
        <title>the_breakthrough_of_glp1-r_peptide:a_new_era_in_diabetes_and_obesity</title>
        <link>https://wiki.brewerideas.ca/doku.php?id=the_breakthrough_of_glp1-r_peptide:a_new_era_in_diabetes_and_obesity&amp;rev=1775555664&amp;do=diff</link>
        <description>In recent years, the medical community has witnessed a surge in interest surrounding GLP1-R (Glucagon-Like Peptide-1 Receptor) peptides, a class of drugs that has shown promising results in the management of type 2 diabetes and obesity. These peptides, which mimic the action of the naturally occurring hormone GLP-1, have opened new avenues for treatment, offering hope to millions of patients worldwide. This article delves into the science behind GLP1-R peptides, their clinical applications, and …</description>
    </item>
</rdf:RDF>
